1.. Resource utility {#S1}
====================

These fluorescent reporter human induced pluripotent stem cell (iPSC) lines created by introducing a tdTomato transgene driven by a constitutive CAG promoter into the established ND2.0 iPSC cell line are useful for cell tracking and sorting *in vitro* and *in vivo* studies concerning human developmental research and disease-modeling.

2.. Resource details {#S2}
====================

The NHLBIi003-A-1 and NHLBIi003-A-2 iPSC reporter cell lines were created by integrating a tdTomato transgene into the AAVS1 safe harbor locus of the established ND2.0 iPSC line with CRISPR/Cas9 ([@R3]; [@R2]). tdTomato is about three times as bright as the widely used green fluorescent protein (GFP), making it the brightest fluorescent protein used in research. Its long emission wavelength and low light absorption by animal tissues also make tdTomato a better candidate than GFP for *in vivo* deep-tissue imaging applications ([@R4]). Furthermore, in our construct, tdTomato expression is under control of the constitutively active CAG promoter ([Supplementary Fig. S1B](#SD1){ref-type="supplementary-material"}), which is one of strongest promoters reported in iPSC and iPSC-derived cells. These advantages coupled with the transgene's stable expression within the safe harbor locus make these tdTomato reporter iPSC lines useful for tracking and sorting iPSCs as well as iPSC-derived cell types grown in co-culture *in vitro*. They will also prove useful for tracking the cells *in vivo* transplantation applications ([Table 1](#T1){ref-type="table"}).

These tdTomato reporter iPSC lines underwent a thorough evaluation after confirming targeted integration of one copy of the CAG-tdTomato transgene at the AAVS1 safe harbor locus with a Southern Blot assay. Targeted integration was confirmed by the expected 3.6 kb band and the remaining wild-type allele was indicated by the presence of the 5.5 kb band ([Supplemental Fig. S1B](#SD1){ref-type="supplementary-material"}). There was no evidence of additional random integrations of the transgene. The iPSC lines maintained stable and robust tdTomato expression and human embryonic stem cell (ESC)-like morphology over extended cell culture. Their undifferentiated state was characterized by immunofluorescent staining and flow cytometry analysis of several common human ESC/iPSC markers including SOX2, NANOG, OCT4, SSEA4, and TRA-1-60 ([Fig. 1A](#F1){ref-type="fig"} and [B](#F1){ref-type="fig"}). FITC or Alexa Fluor 488 conjugated isotype control antibodies were used to stain iPSCs separately for proper gating and measuring the percentages of positive iPSCs stained by pluripotent stem cell marker-specific antibodies ([Table 3](#T3){ref-type="table"}). The percentage of tdTomato positive cells were quantified by flow cytometry, using parental ND2.0 iPSCs as negative control, to confirm that nearly 100% of reporter iPSCs express tdTomato ([Fig. 1B](#F1){ref-type="fig"}). In addition, G-banding karyotyping at passage 42 indicated a normal karyotype (46, XY) ([Supplemental Fig. S1A](#SD1){ref-type="supplementary-material"}) and short tandem repeat (STR) DNA profiling analysis at 15 loci showed the genotypes of these two iPSC lines did match that of the parental ND2.0 line (available with the authors). The cell lines' mycoplasma status was also confirmed to be negative by quantitative PCR (qPCR) ([Supplemental Fig. S1C](#SD1){ref-type="supplementary-material"}). Lastly, pluripotency was demonstrated by a teratoma formation assay in which the cells successfully differentiated into all three germ layers (ectoderm, neural tube; mesoderm, cartilage; endoderm, gut) *in vivo* ([Fig. 1C](#F1){ref-type="fig"}).

3.. Materials and methods {#S3}
=========================

3.1.. CRISPR/Cas9-mediated targeted integration of the tdTomato transgene in human iPSCs {#S4}
----------------------------------------------------------------------------------------

All iPSCs were maintained in cell culture incubators at 37 °C with 5% CO~2~ and 20% O~2~. ND2.0 iPSCs were maintained in a 6-well plate in E8 medium (A1517001, Thermo Fisher) with 1:10 passaging every 3--4 days using the EDTA method ([@R1]). The iPSCs were dissociated with TrypLE (12563029, Thermo Fisher) once they reached 70--90% confluency. 300,000 cells were then re-plated onto one 12-well coated with Matrigel (Corning, 354277) in E8 medium with 10 μl RevitaCell (A2644501, Thermo Fisher). The ND2.0 iPSCs were transfected after they were seeded in the morning and attached 4--6 h later in the afternoon, using Lipofectamine 3000 Transfection Reagent according to the manufacturer's protocol (L3000015, Thermo Fisher). We transfected 1.5 μg of the plasmid pCAG-SpCas9-GFP-U6-gRNA (79144, Addgene) containing the Cas9 protein sequence and the sgRNA targeting the 5′-GGGGCCACTAGGGACAGGAT sequence in the AAVS1 safe harbor locus along with 1.5 μg of the plasmid pAAVS1p-iCAG.copGFP (66577, Addgene) with the cloned tdTomato cassette ([Supplementary Fig. S1B](#SD1){ref-type="supplementary-material"}). E8 medium was added the next day and the cells were passaged after 48 h if confluent. After 2--3 days the iPSCs underwent selection with 0.25 μg/ml puromycin in E8 medium. The medium was changed every day for 7--12 days or until selection was complete and only targeted colonies remained. Colonies were then picked and expanded in E8 medium without puromycin. tdTomato1 and tdTomato4 iPSC clones were selected from these colonies for further characterization.

3.2.. Southern blot {#S5}
-------------------

A Southern blot assay was performed by Lofstrand Labs Limited (Rockville, MD) using a ^32^P labelled PCR probe recognizing the left homology arm as described previously, except that EcoRV and HindIII restriction enzymes were used to digest 10ug genomic DNA ([@R2]). The probe can be used to detect wild-type, targeted integration, and random integration alleles. The wild-type allele is expected to show a 5.5 kb band and the targeted integration allele is expected to show a 3.6 kb band.

3.3.. Immunocytochemistry {#S6}
-------------------------

NHLBIi003-A-1 and NHLBIi003-A-2 iPSCs were fixed and stained as previously described, though we blocked the cells and diluted the primary antibodies with a 10 mg/ml Bovine Serum Albumin (BSA) in DPBS solution ([@R5]). Cell nuclei were stained with DAPI and the cells were imaged with an EVOS^®^ FL Cell Imaging System (Thermo Fisher) and a 10 or 20 × objective lens with Texas Red, FITC, and DAPI filters.

3.4.. Flow cytometry analysis {#S7}
-----------------------------

iPS cells were dissociated from the plate with TrypLE (12563029, Thermo Fisher) and were prepared for flow cytometry as previously described ([@R1]), except that a different permeabilization buffer (2%FBS and 0.2% Tween 20 in DPBS) was used. We used fluorophore conjugated antibodies as listed in [Table 2](#T2){ref-type="table"}. The cells were analyzed with an AccuriC6 Flow Cytometry system (BD Biosciences) and FCS Express 5 software.

3.5.. G-banding karyotyping {#S8}
---------------------------

G-banding karyotyping was performed at passage 42 by WiCell Cytogenetics lab (Madison, WI) using twenty randomly selected metaphases.

3.6.. Short tandem repeat (STR) analysis {#S9}
----------------------------------------

STR analysis was performed by WiCell Cytogenetics lab using a Powerplex^®^ 16 System (Promega) and genomic DNA extracted from the iPSCs with DNeasy Blood and Tissue Kit (Qiagen).

3.7.. Mycoplasma detection {#S10}
--------------------------

2 ml of medium from the iPSC culture was spun down at \> 20,000 g for 20 min to collect a small pellet of cells. After removing all medium, the pellet was lysed by 0.5x Phusion HF Buffer (NEB, \#B0518S) with 8 U/ml Proteinase K (NEB, \#P8107S) at 55 °C for 1--3 h followed by heat-inactivation at 95 °C for 10 min. Quantitative PCR (qPCR) detection of mycoplasma was carried out using the primer pair GPO-1_MGSO with the SsoAdvanced™Universal SYBR Green Supermix (Bio-Rad Laboratories) for 40 cycles. The RFU values at the end of the PCR were used to compare samples with positive (a known contaminated sample) and negative (sterile water) controls to evaluate the presence of mycoplasma contamination. A pair of GAPDH primers (GAPDH-3) that amplify in human samples was used to ensure cell material was present.

3.8.. Teratoma assay {#S11}
--------------------

NHLBIi003-A-1 and NHLBIi003-A-2 iPSCs were removed from 6-well plates when \~90% confluent using the EDTA dissociation method. 1 × 10^7^ cells per clone were resuspended in E8 medium and kept on ice. The suspension was mixed with a 50% volume of cold Matrigel (Corning, 354277) and 150 μl of the resulting mixture was injected subcutaneously into NSG mice (JAX No. 005557) at two sites. Tumors were visible after 6--8 weeks at which point they were removed and fixed in 10% Neutral Buffer Formalin. They were then embedded in paraffin and stained with hematoxylin and eosin.
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![(A) Images of phase contrast and flurorescence microscopy showing the expression of tdTomato and pluripotency markers by ND2-tdTom1 and ND2-tdTom4 iPSCs. (B) Flow cytometry analysis of pluripotency markers of ND2-tdTom1 and ND2-tdTom4 iPSCs. (C) Teratoma formation assay shows ND2-tdTom1 and ND2-tdTom4 iPSCs can generate three germ layers *in vivo*.](nihms-1555301-f0001){#F1}

###### 

Summary of lines.

  iPSC line names   Abbreviation in figures   Gender   Age       Ethnicity   Genotype of locus   Disease
  ----------------- ------------------------- -------- --------- ----------- ------------------- ---------
  NHLBIi003-A-1     ND2-tdTom1                Male     Newborn   Unknown     CAG-tdTomato        N/A
  NHLBIi003-A-2     ND2-tdTom4                Male     Newborn   Unknown     CAG-tdTomato        N/A

###### 

Characterization and validation.

  Classification                                                       Test                                                          Result                                                                                                  Data
  -------------------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------
  Morphology                                                           Photography                                                   Normal                                                                                                  [Fig. 1A](#F1){ref-type="fig"}
  Phenotype                                                            Qualitative analysis: Immunocytochemistry                     Positive for SOX2, OCT4, NANOG, SSEA-4                                                                  [Fig. 1A](#F1){ref-type="fig"}
                                                                       Quantitative analysis: Flow Cytometry (tdTom1, tdTom4)        TRA-1-60 (98.21%, 95.77%); NANOG (99.30%, 92.39%); SSEA-4 (93.11%, 99.46%); tdTomato (99.66%, 99.89%)   [Fig. 1B](#F1){ref-type="fig"}
  Genotype                                                             Karyotype (G-banding) and resolution                          46XY; Resolution 425--500                                                                               [Supplementary Fig. S1A](#SD1){ref-type="supplementary-material"}
  Identity                                                             Microsatellite PCR (mPCR) OR STR analysis                     Not performed                                                                                           N/A
  15 loci plus amelogenin (Promega PowerPlex 16) tested, all matched   Available with the authors                                                                                                                                            
  Mutation analysis (IF APPLICABLE)                                    Sequencing                                                    N/A                                                                                                     N/A
  Southern Blot                                                        Monoallelic targeted integration without random integration   [Supplementary Fig. S1B](#SD1){ref-type="supplementary-material"}                                       
  Microbiology and virology                                            Mycoplasma testing by qPCR                                    Negative                                                                                                [Supplementary Fig. S1C](#SD1){ref-type="supplementary-material"}
  Differentiation potential                                            Teratoma formation                                            Teratoma formed with three germ layers: Ectoderm, Mesoderm, and Endoderm                                [Fig. 1C](#F1){ref-type="fig"}
  Donor screening (OPTIONAL)                                           HIV 1 + 2 Hepatitis B, Hepatitis C                            N/A                                                                                                     N/A
  Genotype additional info (OPTIONAL)                                  Blood group genotyping                                        N/A                                                                                                     N/A
  HLA tissue typing                                                    N/A                                                           N/A                                                                                                     

###### 

Reagents details. RRID Requirement for antibodies: use <http://antibodyregistry.org/> to retrieve RRID for antibodies and include ID in table as shown in examples.

  Antibodies used for immunocytochemistry/flow-cytometry                                                                                   
  -------------------------------------------------------- ------------------------------------------ ------------------------------------ -----------------------------------------------------------
  Pluripotency Markers                                     Mouse anti-SOX2                            1:250                                BioLegend, Cat\# 656102, RRID: AB_2,562246
  Pluripotency Markers                                     Rabbit anti-NANOG                          1:400                                Cell Signaling Technology, Cat\# 4903, RRID: AB_10559205
  Pluripotency Markers                                     Rabbit anti-OCT4                           1:400                                Thermo Fisher, Cat\# 701756, RRID: AB_2633031
  Pluripotency Markers                                     Mouse anti-SSEA4                           1:1000                               Cell Signaling Technology, Cat\# 4755, RRID: AB_1264259
  Secondary Antibodies                                     Donkey anti-Mouse IgG (Alexa Fluor 488)    1:400                                Thermo Fischer, Cat\# A21202, RRID: AB_141607
  Secondary Antibodies                                     Donkey anti-Rabbit IgG (Alexa Fluor 594)   1:400                                Thermo Fischer, Cat\# A21207, RRID: AB_141637
  Flow Cytometry Antibodies                                Anti-Tra-1-60-DyLight 488                  1:50                                 Thermo Fischer, Cat\# MA1--023-D488X, RRID: AB_2536700
  Flow Cytometry Antibodies                                Anti-Nanog-Alexa Fluor 488                 1:50                                 Millipore, Cat\# FCABS352A4, RRID: AB_10807973
  Flow Cytometry Antibodies                                Anti-SSEA-4-Alexa Fluor 488                1:50                                 Thermo Fischer, Cat\# 53-8843-41, RRID: AB_10597752
  Flow Cytometry Antibodies                                Mouse-IgM-DyLight 488                      1:50                                 Thermo Fischer, Cat\# MA1-194-D488, RRID: AB_2536969
  Flow Cytometry Antibodies                                Rabbit IgG-Alexa Fluor 488                 1:50                                 Cell Signaling Technology, Cat\# 4340S, RRID: AB_10694568
  Flow Cytometry Antibodies                                Mouse IgG3-FITC                            1:50                                 Thermo Fischer, Cat\# 11-4742-42, RRID: AB_2043894
  *Primers*                                                                                                                                
                                                           Target                                     Forward/Reverse primer (5′ -- 3′)    
  Mycoplasma detection primers (qPCR)                      GPO-1_MGSO/724bp                           5′-ACGGCCCAGACTCCTACGGGAGGCAGCAGTA   
                                                                                                      5′-CCATGCACCATCTGTCACTCTGTTAACCTC    
  House-keeping gene primers (qPCR)                        GAPDH-3/488 bp                             5′-GGGAGCCAAAAGGGTCATCA              
                                                                                                      5′-TGATGGCATGGACTGTGGTC              

###### 

Resource Table:

  -------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------
  Unique stem cell lines identifier      NHLBIi003-A-1

  NHLBIi003-A-2                          

  Alternative names of stem cell lines   ND2-tdTom1 (NHLBIi003-A-1)

  ND2-tdTom4 (NHLBIi003-A-2)             

  Institution                            National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, USA

  Contact information of distributor     Dr. Jizhong Zou\
                                         <jizhong.zou@nih.gov>

  Type of cell lines                     iPSC

  Origin                                 Human

  Cell Source                            Fibroblast

  Clonality                              Clonal

  Method of reprogramming                Episomal vectors

  Multiline rationale                    Stable and bright fluorescent protein reporter iPSC lines generated from a previously published wild-type iPSC line

  Gene modification                      Yes

  Type of modification                   Transgene expression (fluorescent reporter and drug-resistance genes) by targeted integration

  Associated disease                     N.A.

  Gene/locus                             AAVS1/PPP1R12C

  Method of modification                 CRISPR/Cas9

  Name of transgene or resistance        tdTomato and Puromycin

  Inducible/constitutive system          Constitutive

  Date archived/stock date               September 2019

  Cell line repository/bank              <https://hpscreg.eu/cell-line/NHLBIi003-A-1>\
                                         <https://hpscreg.eu/cell-line/NHLBIi003-A-2>

  Ethical approval                       The original fibroblast CCD-1079sk (ATCC^®^ CRL-2097) was obtained from ATCC (<https://www.atcc.org/products/all/CRL-2097.aspx#specifications>)
  -------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------
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